OPERATION FOR RECURRENT VENTRICULAR-TACHYCARDIA - PREDICTORS OF SHORT-TERM AND LONG-TERM EFFICACY

被引:0
|
作者
LEE, R
MITCHELL, JD
GARAN, H
RUSKIN, JN
MCGOVERN, BA
BUCKLEY, MJ
TORCHIANA, DF
VLAHAKES, GJ
机构
[1] MASSACHUSETTS GEN HOSP, DEPT SURG, CARDIAC SURG UNIT, BOSTON, MA 02114 USA
[2] MASSACHUSETTS GEN HOSP, DEPT MED, CARDIAC UNIT, BOSTON, MA 02114 USA
[3] HARVARD UNIV, SCH MED, BOSTON, MA USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The success of ventricular operation in ablating drug-refractory ventricular tachycardia secondary to ischemic heart disease varies with surgical technique, the presence of certain identified risk factors, and patient selection biases. Forty-eight patients with drug-refractory ventricular tachycardia secondary to ischemic heart disease underwent directed ventricular operation. Ah patients had previous myocardial infarction, and 46 of 48 patients had a left-ventricular aneurysm. Mapping was done in 81% of patients. Patients underwent a combination of subendocardial resection, aneurysmectomy, and cryoablation. The operative mortality rate was 8%. Age greater than 65 years was the only risk factor for operative mortality. Forty-one patients underwent postoperative programmed electrical stimulation. In 26 patients (63%) tachycardia was noninducible, whereas it was inducible in 15 patients (37%). Stepwise logistic regression identified septal and inferior focus location as the most significant predictors of outcome. Septal focus location was a significant (p = 0.008) predictor of surgical success whereas inferior focus location was a significant (p = 0.015) predictor of surgical failure. Other identified independent risk factors for surgical failure were (1) use of cardioplegia, (2) lack of a completed intraoperative endocardial map, and (3) decreased ejection fraction. This generated model to predict success or failure had a sensitivity of 93.3% and a specificity of 92.4%. The success of ventricular operation is affected by the presence of certain risk factors. In the management of those patients at high risk for failure, other surgical options such as the placement of implantable cardioverter-defibrillator electrode patches at the time of ventricular operation or the alternative placement of a palliative implantable cardioverter-defibrillator should be considered.
引用
收藏
页码:732 / 742
页数:11
相关论文
共 50 条
  • [1] MEXILETINE IN THE TREATMENT OF RECURRENT VENTRICULAR-TACHYCARDIA - PREDICTION OF LONG-TERM EFFICACY FROM ACUTE AND SHORT-TERM RESPONSES
    WANG, RYC
    LEE, PK
    WONG, KL
    CHOW, MSS
    DRUG INTELLIGENCE & CLINICAL PHARMACY, 1982, 16 (06): : 483 - 483
  • [2] MEXILETINE IN THE TREATMENT OF RECURRENT VENTRICULAR-TACHYCARDIA - PREDICTION OF LONG-TERM ARRHYTHMIA SUPPRESSION FROM ACUTE AND SHORT-TERM RESPONSE
    WANG, RYC
    LEE, PK
    WONG, KL
    CHOW, MSS
    JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 23 (2-3): : 89 - 92
  • [3] THE ELECTROPHARMACOLOGY AND LONG-TERM EFFICACY OF MEXILETINE IN REFRACTORY VENTRICULAR-TACHYCARDIA
    SAKSENA, S
    GOLDBERG, W
    ROTHBART, S
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 5 (02) : 482 - 482
  • [4] EFFICACY OF INTRAVENOUS AMIODARONE AS SHORT-TERM TREATMENT FOR REFRACTORY VENTRICULAR-TACHYCARDIA
    KLEIN, RC
    MACHELL, C
    RUSHFORTH, N
    STANDEFUR, J
    AMERICAN HEART JOURNAL, 1988, 115 (01) : 96 - 101
  • [5] CLINICAL EFFICACY OF INTRAVENOUS AMIODARONE IN THE SHORT-TERM TREATMENT OF RECURRENT SUSTAINED VENTRICULAR-TACHYCARDIA AND VENTRICULAR-FIBRILLATION
    SCHUTZENBERGER, W
    LEISCH, F
    KERSCHNER, K
    HARRINGER, W
    HERBINGER, W
    BRITISH HEART JOURNAL, 1989, 62 (05): : 367 - 371
  • [6] ELECTROPHYSIOLOGIC PREDICTORS OF LONG-TERM OUTCOME WITH AMIODARONE FOR REFRACTORY VENTRICULAR-TACHYCARDIA
    HAFFAJEE, CI
    GOLD, RL
    YAZAKI, Y
    SLOAN, K
    ALPERT, JS
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (02) : A109 - A109
  • [7] LONG-TERM MANAGEMENT OF SUSTAINED, RECURRENT, SYMPTOMATIC VENTRICULAR-TACHYCARDIA WITH AMIODARONE
    KASKI, JC
    GIROTTI, LA
    MESSUTI, H
    RUTITZKY, B
    ROSENBAUM, MB
    CIRCULATION, 1981, 64 (02) : 273 - 279
  • [8] COMPARISON OF THE RESULTS OF ELECTROPHYSIOLOGIC TESTING AFTER SHORT-TERM AND LONG-TERM TREATMENT WITH AMIODARONE IN PATIENTS WITH VENTRICULAR-TACHYCARDIA
    ROSENHECK, S
    SOUSA, J
    CALKINS, H
    SCHMALTZ, S
    DEBUITLEIR, M
    KADISH, AH
    MORADY, F
    AMERICAN HEART JOURNAL, 1991, 121 (06) : 1693 - 1698
  • [9] LONG-TERM COURSE IN SYMPTOMATIC VENTRICULAR-TACHYCARDIA
    ZVIZDIC, H
    GLOOR, H
    STEINBRUNN, W
    EGLOFF, L
    TURINA, M
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 118 (19) : 708 - 715
  • [10] LONG-TERM PROGNOSIS OF SUSTAINED VENTRICULAR-TACHYCARDIA
    BELLON, C
    KIRKORIAN, G
    BOURRET, N
    RICHALET, C
    BONNEFOY, E
    TOUBOUL, P
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1995, 88 (07): : 1013 - 1019